Emodin was found to protect mice from DSS-induced colitis via the regulation of TLR5/NF-κB signaling pathway [30], and significantly inhibit LPS-mediated NF-κB activation and DNA binding activity in RAW264.7 cells [31]. This evidence concerns the gene TLR5 and colitis.